However, although the incidence of prostate cancer rose rapidly in most countries due to an increase in screening for prostate cancer by prostate-specific antigen (PSA) testing in the 1990s, it has been decreasing in the Netherlands over recent years [3–5]. This evidence concerns the gene KLK3 and prostate cancer.